StockData
Pulmatrix, Inc. logo

Pulmatrix, Inc. (PULM) stock

PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.34−0.03 (-2.19%)

Close on Nov 18, 2026Market cap $4.89MP/E –Yield –

Pulmatrix net income

Net income is the profit left for shareholders after every expense, interest and tax.

Pulmatrix's net income for the twelve months ending Sep 30, 2026 was -$4.35M. For fiscal 2025 it was -$5.16M. The highest annual figure on record is -$5.16M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.16M–
FY2024Dec 31, 2024-$9.56M–
FY2023Dec 31, 2023-$14.12M–
FY2022Dec 31, 2022-$18.84M–
FY2021Dec 31, 2021-$20.17M–
FY2020Dec 31, 2020-$19.31M–
FY2019Dec 31, 2019-$20.60M–
FY2018Dec 31, 2018-$20.56M–
FY2017Dec 31, 2017-$18.06M–
FY2016Dec 31, 2016-$27.84M–
FY2015Dec 31, 2015-$26.17M–
FY2014Dec 31, 2014-$24.14M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$1.21M–
Q2 FY2026Jun 30, 2026-$1.04M–
Q1 FY2026Mar 31, 2026-$1.17M–
Q4 FY2025Dec 31, 2025-$928.00K–
Q3 FY2025Sep 30, 2025-$877.00K–
Q2 FY2025Jun 30, 2025-$1.55M–
Q1 FY2025Mar 31, 2025-$1.81M-319.2%
Q4 FY2024Dec 31, 2024-$1.99M–
Q3 FY2024Sep 30, 2024-$2.59M–
Q2 FY2024Jun 30, 2024-$5.81M–
Q1 FY2024Mar 31, 2024$825.00K–
Q4 FY2023Dec 31, 2023-$2.08M–
Q3 FY2023Sep 30, 2023-$3.77M–
Q2 FY2023Jun 30, 2023-$3.82M–
Q1 FY2023Mar 31, 2023-$4.45M–
Q4 FY2022Dec 31, 2022-$4.22M–
Q3 FY2022Sep 30, 2022-$5.05M–
Q2 FY2022Jun 30, 2022-$4.60M–
Q1 FY2022Mar 31, 2022-$4.97M–
Q4 FY2021Dec 31, 2021-$4.03M–
Q3 FY2021Sep 30, 2021-$8.18M–
Q2 FY2021Jun 30, 2021-$3.85M–
Q1 FY2021Mar 31, 2021-$4.10M–
Q4 FY2020Dec 31, 2020-$2.90M–
Q3 FY2020Sep 30, 2020-$10.55M–
Q2 FY2020Jun 30, 2020-$1.17M–
Q1 FY2020Mar 31, 2020-$4.69M–
Q4 FY2019Dec 31, 2019-$4.04M–
Q3 FY2019Sep 30, 2019-$3.56M–
Q2 FY2019Jun 30, 2019-$7.84M–
Q1 FY2019Mar 31, 2019-$5.16M–
Q4 FY2018Dec 31, 2018-$5.22M–
Q3 FY2018Sep 30, 2018-$4.82M–
Q2 FY2018Jun 30, 2018-$6.19M–
Q1 FY2018Mar 31, 2018-$5.22M–
Q4 FY2017Dec 31, 2017-$4.52M–
Q3 FY2017Sep 30, 2017-$4.45M–
Q2 FY2017Jun 30, 2017-$5.60M–
Q1 FY2017Mar 31, 2017-$3.48M–
Q4 FY2016Dec 31, 2016-$9.83M–

More Pulmatrix figures

See a number that looks wrong?